Abstract |
The ability of MnCl2 to enhance canine myocardium and to delineate ischemic areas is demonstrated. A dose-response curve was measured using T1 weighted images in 11 dogs. MnCl2 (36, 113, 360, and 3600 micromol) was infused over a period of 3 min. Signal intensity increased linearly with MnCl2 dose. At 113 micromol ( approximately 10 micromol/kg) the steady-state increase in intensity averaged 212 +/- 34%. No significant physiologic effects due to the infused MnCl2 were detected except at the highest dose where there was a cardiac depressive effect. Ischemia was induced by occluding the left anterior descending coronary artery in 5 dogs. At an infused dose of 113 micromol, MnCl2 clearly demarcated the ischemic zone during coronary occlusion. Contrast enhancement in the ischemic zone was less than 30% compared with normal tissue (P < 0.03). In conclusion, the intracellular contrast agent MnCl2 enhances the canine heart and shows promise in detecting ischemia at doses that do not cause adverse cardiac effects.
|
Authors | Tom C-C Hu, Timothy F Christian, Anthony H Aletras, Joni L Taylor, Alan P Koretsky, Andrew E Arai |
Journal | Magnetic resonance in medicine
(Magn Reson Med)
Vol. 54
Issue 1
Pg. 196-200
(Jul 2005)
ISSN: 0740-3194 [Print] United States |
PMID | 15968667
(Publication Type: Comparative Study, Evaluation Study, Journal Article, Research Support, N.I.H., Extramural, Research Support, N.I.H., Intramural, Research Support, U.S. Gov't, P.H.S., Validation Study)
|
Chemical References |
- Contrast Media
- Magnesium Chloride
|
Topics |
- Animals
- Contrast Media
- Dogs
- Dose-Response Relationship, Drug
- Heart Ventricles
(drug effects, pathology)
- Image Enhancement
(methods)
- Infusions, Intra-Arterial
- Magnesium Chloride
(administration & dosage)
- Magnetic Resonance Imaging
(methods)
- Myocardial Ischemia
(complications, pathology)
- Reference Values
- Reproducibility of Results
- Sensitivity and Specificity
- Ventricular Dysfunction, Left
(etiology, pathology)
|